NeoGenomics NEO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from NeoGenomics’s reported figures.
Based on trailing twelve months.
The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about NeoGenomics's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NeoGenomics's return on equity?
- NeoGenomics (NEO) reported return on equity of -11.6% in Q1 2026.
- How has NeoGenomics's return on equity changed year-over-year?
- NeoGenomics's return on equity decreased by 34.9% year-over-year, from -8.6% to -11.6%.
- What is the long-term trend for NeoGenomics's return on equity?
- Over 5 years (2020 to 2025), NeoGenomics's return on equity has grown at a 78.1% compound annual growth rate (CAGR), from 0.7% to -12.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.